06 Jan HIV PROVIDER ORGANIZATION TO LAUNCH NEW WEB RESOURCE ON LONG-ACTING AGENTS
Washington, DC: In response to the Food and Drug Administration's recent approval of Apretude (cabotegravir extended-release injectable suspension) for prevention of HIV and the robust pipeline of additional long-acting antiretroviral agents currently under development, the American Academy of HIV Medicine is pleased to announce it...